Home/Medicines/Enoxaparin
All medicines

Enoxaparin

Prescription
Low-Molecular-Weight Heparin (LMWH)
Last reviewed 21 Apr 2026 · PetCare.AI Editorial Team
Species
Dog, Cat
Brands
2 available
Interactions
3 documented
Formulations
1

Mechanism of action

Selectively inhibits Factor Xa via antithrombin III binding. More predictable pharmacokinetics and longer half-life than unfractionated heparin.

At a glance

Class
Low-Molecular-Weight Heparin (LMWH)
Schedule
Prescription
Storage
Store at room temperature below 25°C; do not freeze

Dosing

🐕

Dog

Used for thromboembolic disease
Dose
—
Route
SQ
Frequency
q6h
🐈

Cat

Used for feline ATE prevention and treatment
Dose
1 mg/kg
Route
SQ
Frequency
q6–12h

Formulations

💊

Other — 1

Strength
—

Storage

Store at room temperature below 25°C; do not freeze

Safety

Monitoring parameters

Anti-Xa levelsPCV/TSPlatelet countBleeding signs

Interactions

Major — 2

Meloxicam
major
NSAID platelet dysfunction + LMWH anticoagulation: significantly increased bleeding risk.
Management: Avoid if possible. If both needed, monitor for bleeding (petechiae, melena, hematuria). Use gastroprotectant.
Aspirin (Acetylsalicylic Acid)
major
Aspirin irreversibly inhibits platelet COX-1 (TXA2) + LMWH inhibits Factor Xa: marked additive bleeding risk.
Management: Extreme caution. Only combine under specialist guidance for specific thrombotic conditions (e.g., post-ATE in cats). Monitor bleeding closely.

Moderate — 1

Protamine Sulfate
moderate
Protamine only partially reverses LMWH (~60% of anti-Xa activity neutralized, vs 100% for unfractionated heparin). Incomplete reversal.
Management: Give protamine 1 mg per 100 anti-Xa units of enoxaparin. Expect only partial reversal. May need repeat dosing. Monitor anti-Xa activity.

Brands

Other markets

Lovenox
Clexane

FAQs

Frequently asked questions

›What is Enoxaparin?
Enoxaparin is a low-molecular-weight heparin (lmwh) used in pets. Selectively inhibits Factor Xa via antithrombin III binding. More predictable pharmacokinetics and longer half-life than unfractionated heparin.
›What is Enoxaparin used for in pets?
Enoxaparin is used in veterinary medicine for: Used for thromboembolic disease; Used for feline ATE prevention and treatment.
›What is the Enoxaparin dose for dogs?
For dogs, Enoxaparin is typically dosed as follows — Used for thromboembolic disease: undefined undefined SQ q6h. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›What is the Enoxaparin dose for cats?
For cats, Enoxaparin is typically dosed as follows — Used for feline ATE prevention and treatment: 1 mg/kg SQ q6–12h. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›Does Enoxaparin need a prescription?
Yes. Enoxaparin is a prescription medication and should only be administered under veterinary supervision.

References

References

Textbooks & handbooks

  • Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
  • Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
  • Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
  • National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
  • The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/

Clinical guidelines & consensus

  • Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
  • American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.

Journals & peer-reviewed studies

  • Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
  • Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
  • ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control

Regulatory & approvals

  • Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/

Databases

  • Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet. Find a vet near you →

Related medicines

Other medicines in the same class (Low-Molecular-Weight Heparin).

Dalteparin
Rx
Binds antithrombin III and selectively inhibits Factor Xa, preventing thrombin generation. More predictable pharmacokinetics and longer half-life than unfractionated heparin.
dogcat